29 July 2024
29 July 2024
Several patients are navigating ways to access innovative gene therapies with the help of enterprising research and nonprofit organisations.
The EMA recommended a label update that allows the drug to be used to reduce cardiovascular risk.
The ODAC highlighted that perioperative trials should separately evaluate the effectiveness of treatments pre- and post-operation.
The FDA approval is based on data gathered from two Phase III studies where over 30% of the patients gained 80% or more coverage of scalp hair.
Revenues saw a 9% increase, reaching $12.2bn from $11.2bn in Q2 2023.
The company has fired 25% of its staff and will look for partnerships to further its oncology candidates.
The current approval, which is based on data from non-human primates and healthy individuals, will be updated with real-world observations.
The new project is set to replace the high flux reactor, with operations commencing in the early 2030s.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
